MAY 15, 2022 11:00 AM PDT

Implanted Insulin-producing Cells for Diabetes Treatment

WRITTEN BY: Ryan Vingum

Type 1 diabetes, which affects about 9 to 10 million people globally, occurs when the immune system incorrectly identifies cells that produce insulin in the pancreas as “foreign,” and destroys them. Usually, the body has tools in place to calm an immune system after neutralizing a threat. However, these tools sometimes fail. As a result, the immune system continues to attack insulin-producing cells, which means the body is not making enough insulin to manage glucose levels in the body.

Management of this condition requires careful adherence to certain diet restrictions and administration of insulin, when needed. For many people, though, diabetes can lead to serious complications, including damage to the heart and kidney.

Researchers at the University of Missouri-Columbia have developed a new treatment for type 1 diabetes, and it has proven successful in animal models. The new treatment and results from the animal models are described in a study published in Science Advances

Specifically, the treatment involves the transplantation of islets, or cells that produce insulin. However, unlike other transplantation efforts, there is no need for long-term use of immunosuppressants. 

A big challenge to this kind of transplantation has to do with the body’s incorrect response to insulin-producing cells.. The body’s normal process for shutting down certain immune system cells, a process called apoptosis, or programmed cell death, usually doesn’t work in people with diabetes.

The research team is using the mechanism behind apoptosis to help transplanted insulin-producing cells survive. Specifically, the team is mimicking the interaction between two molecules: FasL, which appear on insulin-producing cells, and Fas, which occur on immune cells. The transplanted insulin-producing cells have an engineered form of FasL on them to prevent the immune system from destroying them.  

A potential benefit of this approach is that it reduces the need for immunosuppressive treatment. Normally, this treatment would be needed to override the immune system and prevent it from destroying these new insulin-producing cells, but this comes with a range of risks and complications. Allowing the cells to exist without messing with the immune system could lead to better outcomes for patients. 

Sources: EurekaAlert!; Science Advances; WHO

About the Author
Professional Writing
Science writer and editor, with a focus on simplifying complex information about health, medicine, technology, and clinical drug development for a general audience.
You May Also Like
JUN 06, 2022
Drug Discovery & Development
Weight loss Surgery Reduces Cancer Risk and Cancer Deaths
JUN 06, 2022
Weight loss Surgery Reduces Cancer Risk and Cancer Deaths
Weight loss achieved via bariatric surgery among adults with obesity is linked to a lower risk of developing cancer and ...
JUN 15, 2022
Drug Discovery & Development
High Intensity Ultrasound Therapy Treats Localized Prostate Cancer
JUN 15, 2022
High Intensity Ultrasound Therapy Treats Localized Prostate Cancer
High-intensity-focused ultrasound (HIFU) can treat some men with prostate cancer instead of surgery or radiation therapy ...
JUL 06, 2022
Drug Discovery & Development
The new amphibious origami millirobot can roll, flip, and spin for targeted drug delivery
JUL 06, 2022
The new amphibious origami millirobot can roll, flip, and spin for targeted drug delivery
Drug delivery researchers are constantly exploring ways that can help improve targeted drug delivery. When a drug is ing ...
JUL 09, 2022
Drug Discovery & Development
Universal Vaccine for Influenza B Shows Promise
JUL 09, 2022
Universal Vaccine for Influenza B Shows Promise
A new universal flu vaccine has been shown to protect against influenza B viruses in cell and mouse models. The correspo ...
JUL 20, 2022
Microbiology
Halting the Assembly of Dangerous Paramyxoviruses Like Nipah
JUL 20, 2022
Halting the Assembly of Dangerous Paramyxoviruses Like Nipah
The paramyxovirus includes serious pathogens that can cause pandemics, including ones that lead primarily to mild. Illne ...
AUG 09, 2022
Immunology
New Small Molecule May Improve Immunotherapy for a Variety of Cancers
AUG 09, 2022
New Small Molecule May Improve Immunotherapy for a Variety of Cancers
Scientists have been trying to stimulate the immune system to fight cancer for decades, and recent years have brought ma ...
Loading Comments...